ClinConnect ClinConnect Logo
Search / Trial NCT04827420

Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Mar 29, 2021

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Smoking Cessation Federally Qualified Health Care Centers Tobacco Quitlines Implementation Science

ClinConnect Summary

The Mi QUIT CARE trial is studying how different messages about quitting smoking can help patients decide to receive support from a smoking cessation coach at the Illinois Tobacco Quitline. Specifically, the trial is comparing two types of messages: one that encourages patients to choose to connect with a coach and another that simply provides information. The researchers want to see which message is more effective in getting patients to speak with a Quitline coach about quitting smoking.

To participate in this trial, you need to be at least 18 years old, currently smoke, speak English, and be a patient at Mile Square Health Center. If you join the study, you will receive messages through a patient portal about quitting smoking. The trial will look at how many patients respond to these messages, how effective they are in encouraging people to get help, and if using the patient portal is a cost-effective way to support smoking cessation. Your involvement could help improve how healthcare providers assist patients in quitting smoking.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged 18 years and older
  • current smoker
  • English speaking
  • Patient at Mile Square Health Center (Main, Englewood, South Shore, Auburn Gresham, Cicero, Back of the Yards)
  • Exclusion Criteria:
  • aged less than 18
  • non-smoker
  • non English speaking
  • Not a patient at MSHC

About University Of Illinois At Chicago

The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Rachel Caskey, MD, MaPP

Principal Investigator

University of Illinois Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials